[Other] Physiologically Based Biopharmaceutics Modeling for Gefapixant IR Formulation Development and Defining the Bioequivalence Dissolution Safe Space

Akash888 Post time 2024-6-17 13:33:09 | Show all posts |Read mode
Reward20points

journal:The AAPS Journal

Authors:Michael Wang; Tycho Heimbach; Wei Zhu; Di Wu; Kevin G. Reuter; Filippos Kesisoglou

Published date:--

DOI:10.1208/s12248-024-00938-2

PDF link:https://link.springer.com/conten ... 248-024-00938-2.pdf

Article link:http://dx.doi.org/10.1208/s12248-024-00938-2

Article Source:Springer Science and Business Media LLC


Remark:

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
green69 Post time 2024-6-17 13:33:10 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    60

Latest Reply

Return to the list